1.9611
+0.0111
+(0.57%)
As of 9:36:19 AM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 27.48k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DODD DAVID A Chief Executive Officer | Purchase at price 1.95 per share. | Direct | 15,600 | Aug 9, 2024 |
| DODD DAVID A Chief Executive Officer | Purchase at price 2.15 - 2.27 per share. | Direct | 19,781 | Feb 22, 2024 |
| REYNOLDS MARK W Chief Financial Officer | Purchase at price 2.77 per share. | Direct | 5,540 | Feb 7, 2024 |
| MCKEE KELLY T JR. Officer | Purchase at price 0.36 per share. | Direct | 2,500 | Dec 22, 2023 |
| MCKEE KELLY T JR. Officer | Purchase at price 0.52 per share. | Direct | 5,020 | Sep 25, 2023 |
| DODD DAVID A Chief Executive Officer | Purchase at price 0.57 per share. | Direct | 20,000 | Aug 25, 2023 |
| REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.52 per share. | Direct | 5,179 | Aug 18, 2023 |
| DODD DAVID A Chief Executive Officer | Purchase at price 0.64 per share. | Direct | 20,445 | Apr 24, 2023 |
| REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.63 per share. | Direct | 5,040 | Apr 20, 2023 |
Related Tickers
VRAX Virax Biolabs Group Limited
1.6700
-1.18%
PBM Psyence Biomedical Ltd.
1.5600
-3.70%
WINT Windtree Therapeutics, Inc.
0.1341
+0.07%
NLSP NLS Pharmaceutics AG
2.8100
+41.92%
CERO CERo Therapeutics Holdings, Inc.
2.0250
+1.76%
ADTX Aditxt, Inc.
0.1076
-1.46%
QNRX Quoin Pharmaceuticals, Ltd.
0.2992
+3.57%
ALLR Allarity Therapeutics, Inc.
1.1600
-1.68%
CNSP CNS Pharmaceuticals, Inc.
0.0974
-2.39%
PHIO Phio Pharmaceuticals Corp.
2.2600
+1.80%